Cite Filings / CRSP / 0000905718-18-000056
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

CRISPR Therapeutics AG · Filed 2018-01-16 · Acc 0000905718-18-000056

Documents 1

  • SC 13D/A Beneficial Ownership Report , crispr13dam2jan52018.htm

Around this filing

  • 2018-02-08 SC 13D/A Beneficial Ownership Report
  • 2018-01-18 4 Chief Legal Officer sold 66,000 shares at an average $28.03 ($1,850,255)
  • 2018-01-16 SC 13D/A Beneficial Ownership Report
  • 2018-01-11 4 Director bought 65,934 shares at $22.75 ($1,499,999)
  • 2018-01-09 4 Director sold 92,337 shares at $26.96 ($2,489,406)
  • 2017-12-26 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · ORBIS INVESTMENT MANAGEMENT LTD 4.7%
  2. 2026-11-13 SCHEDULE 13G/A · ARK Investment Management LLC 10.40%
Loading crispr13dam2jan52018.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…